Skip to search Skip to main content

Govt building Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure accsess Secure .gov websites use HTTPS
A lock ( Lock A locked padlock ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

NLM Digital Collections
    • About
    • Help
    • Web Service

    « Previous Next »
    A-Z Sort Numerical Sort

    Titles

    1. All
    2. A
    3. B
    4. C
    5. D
    6. E
    7. F
    8. G
    9. H
    10. I
    11. J
    12. K
    13. L
    14. M
    15. N
    16. O
    17. P
    18. Q
    19. R
    20. S
    21. T
    22. U
    23. V
    24. W
    25. X
    26. Y
    27. Z
    • CDC found ways to use data to understand and address COVID-19 health disparities, despite challenges with existing data1
    • CDC generally met its inspection goals for the federal select agent program: however, opportunities exist to strengthen oversight1
    • CDC has improved the nursing home reporting process for COVID-19 Data in NHSN, but challenges remain1
    • CDC provided oversight and assistance: however, ELC recipients still faced challenges in implementing COVID-19 screening testing programs1
    • CDC standard rubella hemagglutination-inhibition test1
    • CDC’S Vaccines for Children program recipients did not conduct site visits at some providers as required1
    • CDC’s internal control weaknesses led to its initial COVID-19 test kit failure, but CDC ultimately created a working test kit1
    • CDER’s program for the recognition of voluntary consensus standards related to pharmaceutical quality: guidance for industry1
    • CEA1
    • CEG says: MIS abuse leads to MISfortune1
    • CMC postapproval manufacturing changes for specified biological products to be documented in annual reports2
    • CMS Innovation Center: model implementation and center performance : report to Congressional requesters1
    • CMS can do more to leverage Medicare claims data to identify unreported incidents of potential abuse or neglect1
    • CMS could improve the data it uses to monitor antipsychotic drugs in nursing homes1
    • CMS did not detect some inappropriate claims for durable medical equipment in nursing facilities1
    • CMS has opportunities to strengthen states’ oversight of Medicaid Managed Care Plans’ reporting of medical loss ratios1
    • CMS should bolster its oversight of manufacturer-submitted average sales price data to ensure accurate Part B drug payments1
    • CMS should pursue strategies to increase the number of at-risk beneficiaries acquiring naloxone through Medicaid1
    • CMS should take further action to address states with poor performance in conducting nursing home surveys1
    • CMS use of data on nursing home staffing: progress and opportunities to do more1
    « Previous Next »
    A-Z Sort Numerical Sort

    Connect with NLM

    • Facebook
    • LinkedIn
    • Twitter
    • You Tube

    National Library of Medicine
    8600 Rockville Pike
    Bethesda, MD 20894

    Web Policies
    FOIA
    HHS Vulnerability Disclosure

    NLM Support Center
    Accessibility
    Careers

    NLM | NIH | HHS | USA.gov